- Filed
- May 7, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Apr 30, 2024 | 74.4M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 75.27M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 74.37M sh |
| Capex | Q1 2024 · Mar 31, 2024 | $1.07M |
| Capex | Q1 2024 · Mar 31, 2023 | $220K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | $47.42M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | $39.13M |
| Long Term Debt | Q1 2024 · Mar 31, 2024 | $93.57M |
| Long Term Debt | Q1 2024 · Dec 31, 2023 | $93.54M |
| Short Term Investments | Q1 2024 · Mar 31, 2024 | $20.57M |
| Short Term Investments | Q1 2024 · Dec 31, 2023 | $18M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $247.63M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $217.68M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $1.31B |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $1.27B |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $1.15B |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $1.13B |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $69.25M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $75.84M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $347.31M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $353.18M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $322.09M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $291.11M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $1.66B |
| Total Assets | Q1 2024 · Dec 31, 2023 | $1.62B |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | $0.50 |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | $0.23 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | $0.51 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | $0.23 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $27.32M |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $25.69M |
| Net Income | Q1 2024 · Mar 31, 2024 | $37.96M |
| Net Income | Q1 2024 · Mar 31, 2023 | $17.22M |
| Revenue | Q1 2024 · Mar 31, 2024 | $190.27M |
| Revenue restated | Q1 2024 · Mar 31, 2023 | $170.3M |